Cite
MLA Citation
S. Sukumar et al.. “Characterization of MK-4166, a clinical agonistic mAb that targets human GITR and inhibits the generation and activity of Tregs.” European journal of cancer, vol. 69, n.d., pp. S104–. http://access.bl.uk/ark:/81055/vdc_100039473424.0x000037